Creatine Benefits Beyond Muscle: Emerging Research on Brain Health, Metabolism, and Longevity

Creatine has been around for decades. I leaned on it big time in my early career days (both as a physician and a competitive cyclist). I lectured on it in my second year of medical school. And as an athlete, I had firsthand experience of creatine’s most common side effect – water retention. I saw visible changes in my face and swelling in my ankles as I loaded on creatine before a big athletic event, dropping the dose afterwards. Even so, creatine has consistently demonstrated an excellent safety profile when used appropriately. What excites me now is its potential to benefit other areas, such as brain and cardiovascular health, and its validation by the latest research. In this 2-part article, we explore the latest research on creatine’s health benefits, clinical uses, dosing strategies, and potential side effects. Take a read; you may be surprised by some of the findings!   ~DrKF

 

Article written by Miranda Kusi, MS CNS FMCP

 

Creatine, first identified in the 19th century and popularized in the 1990s, is now experiencing a second renaissance that extends well beyond sports performance into mainstream clinical and research settings. Digital media, search trends, and market growth reflect a sharp rise in interest, while scientific output has expanded to thousands of publications annually, making creatine one of the most extensively studied nutritional compounds.

Physiologically, creatine is a central regulator of cellular energy, supporting ATP regeneration through the creatine kinase-phosphocreatine system in tissues with high metabolic demand, including muscle, brain, heart, and retina. It further influences cellular hydration, redox balance, and methylation demand, positioning it as a pleiotropic molecule with relevance across aging, metabolic dysfunction, and chronic disease. Read on to explore how these mechanisms translate into wide-ranging clinical and longevity benefits across multiple organ systems.

Key Takeaways

• Creatine is a core bioenergetic molecule, not just a sports supplement.
• Muscle, brain, and cardiometabolic benefits have the most consistent scientific evidence.
• Clinical outcomes are greatest when combined with exercise and resistance training.
• Emerging data link creatine to longevity and healthier aging, though prospective and interventional trials are still needed.
• Creatine’s role is pleiotropic, influencing ATP buffering, mitochondrial function, osmotic balance, redox status, and methylation demand.

 

How Creatine Supports Muscle Energy, Recovery, and Exercise Performance

Approximately 95% of the body’s creatine is stored in skeletal muscle, primarily in its phosphorylated form, where it exists in dynamic equilibrium with ATP. Since skeletal muscle cannot synthesize it, muscle cells actively uptake creatine from the circulation via a sodium- and chloride-dependent transporter that functions against a concentration gradient. Once inside the cell, creatine becomes effectively “trapped” through its conversion to phosphocreatine (PCr) and other mechanisms.

This helps explain why supplementation has such pronounced physiological effects. Creatine’s ergogenic (performance-enhancing) properties have now been documented in hundreds of clinical studies. It is well established that creatine supplementation reliably increases intramuscular creatine and PCr concentrations. Higher PCr availability supports faster ATP regeneration between repeated bouts of intense activity, allowing individuals to train at greater intensities and volumes.

Beyond supporting rapid ATP resynthesis, PCr may also help buffer intracellular hydrogen ions that accumulate with lactate production during high-intensity exercise. This buffering capacity may delay fatigue and reduce muscle and blood lactate levels, although further research is needed to fully confirm this mechanism. Creatine may also enhance recovery and reduce post-exercise muscle damage. Its effects on post-exercise inflammation remain less clear, with preliminary data showing mixed and sometimes contradictory results.

Although findings on muscle strength are not entirely consistent, several clinical trials demonstrate improvements with creatine supplementation. These benefits are partly explained by small increases in muscle size. And while creatine-related hypertrophy is associated with greater intracellular water content, it does not appear to alter the normal ratio of intracellular water to muscle tissue*. Supporting this, a meta-analysis of small randomized trials in adults undergoing resistance training found that creatine supplementation (5-20 g/day for 6-52 weeks) produced modest but statistically significant increases in upper- and lower-body hypertrophy compared to placebo, with slightly greater effects in younger adults.

Is There A Muscle-Adipose-Creatine Axis? On our recent New Frontiers podcast, Dr. Gabrielle Lyon emphasized the clinical importance of muscle quality and the association between intramuscular adipose tissue and metabolic dysfunction. Given creatine’s benefits for strength and endurance, a key question is whether it may also improve muscle quality and reduce intramuscular fat. To date, no human data directly addresses this (as far as we’re aware). However, animal studies suggest that creatine may increase energy expenditure and thermogenesis in brown adipose tissue via a so-called “futile creatine cycle,” which has been implicated in weight loss and obesity prevention. Current research remains limited, and at least one study found no change in total body fat with creatine supplementation*.

 

Can Creatine Improve Brain Health? Emerging Research on Cognition and Neuroprotection

Beyond exercise performance, interest in creatine’s potential benefits in other areas, such as brain health and cognition, has grown rapidly. Given its central role in cellular energy metabolism, this is not surprising. Some researchers have even speculated that higher creatine intake in early hominid diets may have supported the evolution of our species by supporting larger brain size of infants at birth.

Although public enthusiasm is high, clinical data on cognitive outcomes are still emerging. There is, however, evidence that creatine crosses the blood-brain barrier via a dedicated transporter. It’s also known that disruptions in creatine synthesis or transport, as in the case of creatine deficiency disorders, are associated with profound cognitive impairment, underscoring its essential role in brain function. The presence of a brain-specific creatine kinase further highlights its importance in central nervous system energy metabolism.

As in skeletal muscle, creatine appears particularly beneficial during states of metabolic stress or energy deficit, such as sleep deprivation, traumatic brain injury, and neurodegenerative diseases including Parkinson’s and Alzheimer’s disease. Increasing brain creatine availability may help restore ATP buffering capacity under these conditions, as emerging evidence suggests.

In a first-of-its-kind clinical trial*, patients with Alzheimer’s disease who received 20 g/day of creatine for 8 weeks demonstrated an average 11% increase in total brain creatine, with measurable rises in 85% of participants. This biochemical change was accompanied by a 4.4% improvement in global cognitive performance on the NIH Toolbox. Importantly, greater increases in brain creatine were associated with larger cognitive gains, suggesting a potential dose-response relationship. These findings support the hypothesis that creatine may address underlying bioenergetic dysfunction in Alzheimer’s disease, including impaired mitochondrial function, reduced ATP availability, and disrupted creatine metabolism. Larger trials are now needed to confirm these effects.

Creatine may also mitigate cognitive changes associated with estrogen deficiency* and mild traumatic brain injury (mTBI). In the CONCRET-MENOPA trial*, a daily dose of 1.5 g of creatine hydrochloride significantly improved cognitive performance and increased frontal brain creatine levels in perimenopausal and menopausal women within 8 weeks. Although the sample size was small (n=36), these results highlight creatine’s promise as a potential intervention for cognitive, emotional, and metabolic vulnerabilities during the menopausal transition.

Interestingly, creatine is a key osmolyte in the central nervous system, helping regulate intracellular water content and cellular volume. This osmotic effect may be neuroprotective during conditions such as cerebral edema, traumatic injury, and metabolic stress.

Creatine and the Brain-Muscle Axis. Emerging evidence suggests that creatine may influence brain health indirectly by modulating myokine signaling, a key pathway through which skeletal muscle communicates with the brain. By enhancing muscular energy availability, promoting hypertrophy, and improving insulin sensitivity, creatine may alter the release of myokines* such as IL-6, IGF-1, irisin, and BDNF, all of which cross the blood-brain barrier and influence cognition, mood, and neuroplasticity.

 

Despite these promising findings, it’s important to critically evaluate emerging data and acknowledge the need for larger, methodologically rigorous trials to avoid overinterpretation and ensure responsible clinical translation.

 

Creatine Benefits for Cardiovascular Health, Glucose Metabolism, and Metabolic Function

Creatine has also demonstrated potential benefits for cardiovascular and metabolic health, including improvements in glucose metabolism, endothelial function, and lipid profiles. In a randomized, placebo-controlled crossover study* of healthy adults, 4 weeks of creatine supplementation improved macrovascular function by 1.2% and microvascular function by 1.4% – changes previously associated with meaningful reductions in future cardiovascular risk. Participants also experienced modest but clinically relevant metabolic improvements, including a reduction in fasting glucose (103 → 99 mg/dL) and triglycerides (100 → 84 mg/dL).

These effects may be mediated through multiple complementary mechanisms*, including enhanced endothelial energy reserves, reduced oxidative stress, improved mitochondrial function, membrane stabilization, and favorable effects on nitric oxide bioavailability and lipid metabolism.

Human evidence regarding creatine’s effects on glycemic control remains limited to small, short-term studies. Preclinical data* suggest potential benefits through enhanced insulin secretion and increased muscle glycogen storage. The most consistent metabolic improvements appear when creatine is combined with exercise*, likely through increased GLUT4 translocation and skeletal muscle glucose uptake. This has important clinical implications for reducing type 2 diabetes risk in older adults, particularly in the presence of sarcopenia.

 

New Research on Creatine Benefits for Bone Density, Mood, and Sleep

Although creatine supplementation has been used since the early 90s, research continues to uncover new therapeutic roles beyond athletic performance. Below are several promising, though still evolving, areas of clinical interest.

• Bone health: Creatine may indirectly help preserve bone by increasing mechanical loading through improved muscle strength and by supporting osteoblast function while reducing osteoclast-mediated resorption*. In humans, the most consistent benefits are observed when creatine is combined with resistance or impact exercise, with modest preservation of bone density and structure at weight-bearing sites, particularly in postmenopausal women. However, creatine alone has not been shown to increase bone density with aging.*
• Anti-inflammatory properties: Early in vitro and animal studies suggested that creatine may reduce inflammatory mediators such as TNF-α and certain interleukins. However, these findings have not been consistently replicated in humans.* Current evidence indicates that any anti-inflammatory effects may be species- and model-specific. In addition, emerging mechanistic data suggest that creatine could modulate the NF-κB pathway via downregulation of toll-like receptors.* While this may hold therapeutic promise for inflammatory conditions, conflicting results highlight the need for further mechanistic and clinical research.
• Mood regulation, anxiety and depression: Some researchers consider creatine a neurotransmitter because it is synthesized in neurons, released in an activity-dependent manner, and can act on postsynaptic receptors, including as a partial agonist of GABA receptors. These GABAergic properties may be relevant in conditions such as epilepsy, post-traumatic brain injury, and glutamate excitotoxicity. Creatine may also interact with postsynaptic serotonin receptors, contributing to antidepressant-like effects. In one 8-week trial, creatine used as an adjunct to cognitive behavioral therapy significantly reduced depression scores, and other studies suggest that creatine may potentiate conventional antidepressant treatment.
• Sleep support: Small randomized controlled trials suggest that creatine may improve sleep duration during periods of high physical or cognitive stress and help preserve cognitive function following sleep deprivation. In an acute sleep deprivation study, a single high dose of creatine (≈0.35 g/kg) increased brain PCr, reduced fatigue, and preserved cognitive performance. In a separate 6-week trial*, daily low-dose creatine (5 g) increased sleep duration by nearly 50 minutes on resistance-training days. Clinically, these findings suggest that creatine may be a useful add-on to mitigate fatigue, cognitive decline, and sleep disruption in individuals exposed to acute sleep loss, heavy training, or other metabolic stressors.

 

Creatine for Healthy Aging: Supporting Muscle, Brain, and Longevity

Taken together, creatine’s mechanisms of action and emerging benefits indicate a broader role in healthy aging and longevity.

Creatine stores naturally decline with age due to reduced dietary intake, impaired endogenous synthesis, physical inactivity, and loss of muscle mass. These changes contribute not only to sarcopenia and functional decline but also to an increased risk of other chronic diseases where creatine plays a key role, such as cognitive impairment and cardiometabolic dysfunction.

Clinical trials and meta-analyses demonstrate that creatine supplementation (≥5 g/day or 0.1–0.3 g/kg), when combined with resistance training, significantly improves muscle strength, lean mass, and functional performance in adults aged 50-80+, thereby reducing the risk of frailty, muscle wasting, and falls. Creatine alone, however, is unlikely to produce meaningful benefits without exercise and supportive lifestyle interventions. Nevertheless, it represents a low-cost, evidence-based adjunct to resistance training for healthy aging.

Excitingly, emerging epidemiologic data also suggest that higher creatine intake may be associated with slower biological aging*, as assessed by DNA methylation-derived mortality indices. A population-based study* found that greater dietary creatine intake was significantly associated with lower epigenetic mortality risk scores using the GrimAgeMort and GrimAge2Mort clocks. However, this study relied on a single 24-hour dietary recall, excluded supplemental creatine, used older NHANES data (1999–2002), and was cross-sectional in nature. As such, the findings establish association, not causation, and require confirmation in prospective and interventional trials.

 

Creatine as a Foundational Nutrient for Muscle, Brain, and Healthy Aging

Creatine has moved far beyond sports nutrition to become a clinically relevant, pleiotropic molecule with benefits across muscle, brain, and cardiometabolic systems. By supporting ATP regeneration, cellular hydration, redox balance, and methylation, creatine helps preserve function in tissues with high energy demand and during states of metabolic stress and aging.

Clinical evidence consistently shows that creatine, especially when combined with resistance training, improves muscle bioenergetics and functional capacity, with emerging data supporting roles in cognitive health, vascular function, glucose metabolism, menopause transition, and healthy aging. As a low-cost, well-studied intervention, creatine represents a practical addition to lifestyle-based therapies.

Coming next month: In Part 2 of this blog series, we will cover practical creatine use cases, dosing strategies, and different formulations; patient populations that may benefit from creatine and those where it should be used with caution; and the current data on potential side effects. This next installment will also include a downloadable clinician’s guide to creatine to support safe and evidence-based implementation in practice.

 

*Disclaimer: One or more authors of the asterisked citation have affiliations with supplement companies, including those that manufacture or sell creatine. For more details, check the citation’s “Conflicts of Interest” or “Ethics Declaration” section typically found at the bottom of the research paper.